IONS Q1 2018 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$144M+24.7% YoY

Gross Profit

$144M100.0% margin

Operating Income

-$3M-2.3% margin

Net Income

-$1M-1.0% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

-16.2%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$10M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$912M

Stockholders' Equity

$301M

Cash & Equivalents

$228M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$144M	$116M	+24.7%
Gross Profit	$144M	$33M	+335.5%
Operating Income	-$3M	$19M	-116.9%
Net Income	-$1M	$9M	-115.8%

Revenue Segments

Commercial

$42M50%

SPINRAZA Royalties

$41M49%

Licensing and Other Royalties

$942,0001%